Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| IO Biotech, Inc. | 35,144 | reported | 05 Jun 2025 | tx 3+145,024 |
| Kura Oncology, Inc. | 28,500 | reported | 05 Jun 2025 | tx 6+168,666 |
| Enliven Therapeutics, Inc. | 25,000 | reported | 18 May 2026 | tx 32+1,179,900−311,632 |
| FIVE PRIME THERAPEUTICS INC | 0 | reported | 16 Apr 2021 | tx 48+545,344−608,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 18 May 2026 | EXERCISE | Enliven Therapeutics, Inc. | 5,000 | 2.48 USD | 10b5-1 |
| 18 May 2026 | SALE | Enliven Therapeutics, Inc. | 3,475 | 39.53 USD | 10b5-1 |
| 18 May 2026 | SALE | Enliven Therapeutics, Inc. | 1,302 | 40.25 USD | 10b5-1 |
| 18 May 2026 | SALE | Enliven Therapeutics, Inc. | 223 | 41.21 USD | 10b5-1 |
| 18 May 2026 | EXERCISE | Enliven Therapeutics, Inc. | 5,000 | 0.00 USD | 10b5-1deriv |
| 25 Mar 2026 | EXERCISE | Enliven Therapeutics, Inc. | 40,000 | 2.48 USD | |
| 25 Mar 2026 | SALE | Enliven Therapeutics, Inc. | 40,000 | 35.10 USD | |
| 25 Mar 2026 | EXERCISE | Enliven Therapeutics, Inc. | 40,000 | 0.00 USD | deriv |
| 17 Mar 2026 | SALE | Enliven Therapeutics, Inc. | 5,000 | 27.76 USD | |
| 17 Mar 2026 | EXERCISE | Enliven Therapeutics, Inc. | 5,000 | 2.48 USD | |
| 17 Mar 2026 | EXERCISE | Enliven Therapeutics, Inc. | 5,000 | 0.00 USD | deriv |
| 10 Mar 2026 | SALE | Enliven Therapeutics, Inc. | 10,129 | 30.19 USD | |
| 10 Mar 2026 | EXERCISE | Enliven Therapeutics, Inc. | 10,129 | 2.48 USD | |
| 09 Mar 2026 | SALE | Enliven Therapeutics, Inc. | 29,871 | 30.02 USD | |
| 09 Mar 2026 | EXERCISE | Enliven Therapeutics, Inc. | 29,871 | 2.48 USD | |
| 10 Mar 2026 | EXERCISE | Enliven Therapeutics, Inc. | 10,129 | 0.00 USD | deriv |
| 09 Mar 2026 | EXERCISE | Enliven Therapeutics, Inc. | 29,871 | 0.00 USD | deriv |
| 17 Feb 2026 | SALE | Enliven Therapeutics, Inc. | 45,000 | 26.17 USD | |
| 17 Feb 2026 | EXERCISE | Enliven Therapeutics, Inc. | 45,000 | 2.48 USD | |
| 17 Feb 2026 | EXERCISE | Enliven Therapeutics, Inc. | 45,000 | 0.00 USD | deriv |
| 12 Feb 2026 | GRANT_AWARD | Enliven Therapeutics, Inc. | 25,000 | 0.00 USD | |
| 12 Feb 2026 | GRANT_AWARD | Enliven Therapeutics, Inc. | 150,000 | 0.00 USD | deriv |
| 05 Jun 2025 | GRANT_AWARD | Kura Oncology, Inc. | 28,500 | 0.00 USD | deriv |
| 05 Jun 2025 | GRANT_AWARD | IO Biotech, Inc. | 35,144 | 0.00 USD | deriv |
| 06 Feb 2025 | GRANT_AWARD | Enliven Therapeutics, Inc. | 171,000 | 0.00 USD | deriv |